Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF) › Operating IncomeCordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2021: -$119.4K2022: -$415.1K2023: $227.8K2024: -$183.9K2025: -$141.1K-$141.1K2021Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$141.1K+23.3%2024-$183.9K-180.7%2023$227.8K+154.9%2022-$415.1K-247.7%2021-$119.4K—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share